Nektar Therapeutics (NKTR) Goodwill (2010 - 2022)

Nektar Therapeutics' Goodwill history runs 13 years deep, the most recent figure standing at $76.5 million for Q4 2022.

• In Q4 2022, Goodwill changed 0.0% year-over-year to $76.5 million; the TTM figure through Dec 2022 stood at $76.5 million (changed 0.0% YoY), while the FY2022 annual figure was $76.5 million, changed 0.0% from the prior year.
• Goodwill for Q4 2022 stood at $76.5 million, roughly flat from $76.5 million in the prior quarter.
• The five-year high for Goodwill was $76.5 million in Q1 2018, with the low at $76.5 million in Q1 2018.
• The 5-year median for Goodwill is $76.5 million (2018), against an average of $76.5 million.
• Peak annual rise in Goodwill reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
• Nektar Therapeutics' Goodwill stood at $76.5 million in 2018, then changed by 0.0% to $76.5 million in 2019, then changed by 0.0% to $76.5 million in 2020, then changed by 0.0% to $76.5 million in 2021, then changed by 0.0% to $76.5 million in 2022.
• Business Quant data shows NKTR's Goodwill at $76.5 million in Q4 2022, $76.5 million in Q3 2022, and $76.5 million in Q2 2022.